BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18784748)

  • 1. Polymeric gene delivery of ischemia-inducible VEGF significantly attenuates infarct size and apoptosis following myocardial infarct.
    Yockman JW; Choi D; Whitten MG; Chang CW; Kastenmeier A; Erickson H; Albanil A; Lee M; Kim SW; Bull DA
    Gene Ther; 2009 Jan; 16(1):127-35. PubMed ID: 18784748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmid-mediated VEGF gene transfer induces cardiomyogenesis and reduces myocardial infarct size in sheep.
    Vera Janavel G; Crottogini A; Cabeza Meckert P; Cuniberti L; Mele A; Papouchado M; Fernández N; Bercovich A; Criscuolo M; Melo C; Laguens R
    Gene Ther; 2006 Aug; 13(15):1133-42. PubMed ID: 16572192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy of neural cell injuries in vitro using the hypoxia-inducible GM-CSF expression plasmids and water-soluble lipopolymer (WSLP).
    Kim JM; Lee M; Kim KH; Ha Y; Choi JK; Park SR; Park H; Park HC; Ahn CH; Kim SW; Choi BH
    J Control Release; 2009 Jan; 133(1):60-7. PubMed ID: 18938203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor-165 gene therapy promotes cardiomyogenesis in reperfused myocardial infarction.
    Guerrero M; Athota K; Moy J; Mehta LS; Laguens R; Crottogini A; Borrelli M; Corry P; Schoenherr D; Gentry R; Boura J; Grines CL; Raff GL; Shanley CJ; O'Neill WW
    J Interv Cardiol; 2008 Jun; 21(3):242-51. PubMed ID: 18422517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Water-soluble lipopolymer as an efficient carrier for gene delivery to myocardium.
    Lee M; Rentz J; Han SO; Bull DA; Kim SW
    Gene Ther; 2003 Apr; 10(7):585-93. PubMed ID: 12646864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined cord blood stem cells and gene therapy enhances angiogenesis and improves cardiac performance in mouse after acute myocardial infarction.
    Chen HK; Hung HF; Shyu KG; Wang BW; Sheu JR; Liang YJ; Chang CC; Kuan P
    Eur J Clin Invest; 2005 Nov; 35(11):677-86. PubMed ID: 16269017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction.
    Deuse T; Peter C; Fedak PW; Doyle T; Reichenspurner H; Zimmermann WH; Eschenhagen T; Stein W; Wu JC; Robbins RC; Schrepfer S
    Circulation; 2009 Sep; 120(11 Suppl):S247-54. PubMed ID: 19752375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient siRNA delivery using water soluble lipopolymer for anti-angiogenic gene therapy.
    Kim WJ; Chang CW; Lee M; Kim SW
    J Control Release; 2007 Apr; 118(3):357-63. PubMed ID: 17313987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer.
    Lee M; Rentz J; Bikram M; Han S; Bull DA; Kim SW
    Gene Ther; 2003 Sep; 10(18):1535-42. PubMed ID: 12907944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial angiogenesis after plasmid or adenoviral VEGF-A(165) gene transfer in rat myocardial infarction model.
    Hao X; Månsson-Broberg A; Grinnemo KH; Siddiqui AJ; Dellgren G; Brodin LA; Sylvén C
    Cardiovasc Res; 2007 Feb; 73(3):481-7. PubMed ID: 17134685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel polymer carriers and gene constructs for treatment of myocardial ischemia and infarction.
    Yockman JW; Kastenmeier A; Erickson HM; Brumbach JG; Whitten MG; Albanil A; Li DY; Kim SW; Bull DA
    J Control Release; 2008 Dec; 132(3):260-6. PubMed ID: 18662730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow mononuclear cell therapy limits myocardial infarct size through vascular endothelial growth factor.
    Hiasa K; Egashira K; Kitamoto S; Ishibashi M; Inoue S; Ni W; Zhao Q; Nagata S; Katoh M; Sata M; Takeshita A
    Basic Res Cardiol; 2004 May; 99(3):165-72. PubMed ID: 15088101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VEGF165 and angiopoietin-1 decreased myocardium infarct size through phosphatidylinositol-3 kinase and Bcl-2 pathways.
    Zhou L; Ma W; Yang Z; Zhang F; Lu L; Ding Z; Ding B; Ha T; Gao X; Li C
    Gene Ther; 2005 Feb; 12(3):196-202. PubMed ID: 15510173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects for acute phase myocardial infarct VEGF165 gene transfer cardiac extracellular matrix remodeling.
    Mataveli FD; Han SW; Nader HB; Mendes A; Kanishiro R; Tucci P; Lopes AC; Baptista-Silva JC; Marolla AP; de Carvalho LP; Denapoli PM; Pinhal MA
    Growth Factors; 2009 Feb; 27(1):22-31. PubMed ID: 19107652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining angiogenic gene and stem cell therapies for myocardial infarction.
    Pons J; Huang Y; Takagawa J; Arakawa-Hoyt J; Ye J; Grossman W; Kan YW; Su H
    J Gene Med; 2009 Sep; 11(9):743-53. PubMed ID: 19554624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound-mediated microbubble destruction enhances VEGF gene delivery to the infarcted myocardium in rats.
    Zhigang W; Zhiyu L; Haitao R; Hong R; Qunxia Z; Ailong H; Qi L; Chunjing Z; Hailin T; Lin G; Mingli P; Shiyu P
    Clin Imaging; 2004; 28(6):395-8. PubMed ID: 15531137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation of microencapsulated genetically modified xenogeneic cells augments angiogenesis and improves heart function.
    Zhang H; Zhu SJ; Wang W; Wei YJ; Hu SS
    Gene Ther; 2008 Jan; 15(1):40-8. PubMed ID: 17943144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Construction of VEGF recombinant plasmid pcDNA/V and its expression in model rats with acute myocardial ischemia].
    Wang YM; Liu B; Sun LC; Yan YD; Si Y; Qi YH
    Sheng Wu Gong Cheng Xue Bao; 2006 Mar; 22(2):220-5. PubMed ID: 16607947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms.
    Lähteenvuo JE; Lähteenvuo MT; Kivelä A; Rosenlew C; Falkevall A; Klar J; Heikura T; Rissanen TT; Vähäkangas E; Korpisalo P; Enholm B; Carmeliet P; Alitalo K; Eriksson U; Ylä-Herttuala S
    Circulation; 2009 Feb; 119(6):845-56. PubMed ID: 19188502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Water-soluble lipopolymer as a gene carrier to corpus cavernosum.
    Lee M; Ryu JK; Oh SM; Lee E; Shin HY; Song SU; Kim SW; Suh JK
    Int J Impot Res; 2005; 17(4):326-34. PubMed ID: 15800653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.